Feigenspan, Andreas, Stefano Gustincich, and Elio Raviola. Pharmacology of GABA A receptors of retinal dopaminergic neurons. J Neurophysiol 84: [1697][1698][1699][1700][1701][1702][1703][1704][1705][1706][1707] 2000. When the vertebrate retina is stimulated by light, a class of amacrine or interplexiform cells release dopamine, a modulator responsible for neural adaptation to light. In the intact retina, dopamine release can be pharmacologically manipulated with agonists and antagonists at GABA A receptors, and dopaminergic (DA) cells receive input from GABAergic amacrines. Because there are only 450 DA cells in each mouse retina and they cannot be distinguished in the living state from other cells on the basis of their morphology, we used transgenic technology to label DA cells with human placental alkaline phosphatase, an enzyme that resides on the outer surface of the cell membrane. We could therefore identify DA cells in vitro after dissociation of the retina and investigate their activity with whole cell voltage clamp. We describe here the pharmacological properties of the GABA A receptors of solitary DA cells. GABA application induces a large inward current carried by chloride ions. The receptors are of the GABA A type because the GABAevoked current is blocked by bicuculline. Their affinity for GABA is very high with an EC 50 value of 7.4 M. Co-application of benzodiazepine receptor ligands causes a strong increase in the peak current induced by GABA (maximal enhancement: CL-218872 220%; flunitrazepam 214%; zolpidem 348%) proving that DA cells express a type I benzodiazepine-receptor (BZ1). GABA-evoked currents are inhibited by Zn 2ϩ with an IC 50 of 58.9 Ϯ 8.9 M. Furthermore, these receptors are strongly potentiated by the modulator alphaxalone with an EC 50 of 340 Ϯ 4 nM. The allosteric modulator loreclezole increases GABA receptor currents by 43% (1 M) and by 107% (10 M). Using outside-out patches, we measured in single-channel recordings a main conductance (29 pS) and two subconductance (20 and 9 pS) states. We have previously shown by single-cell RT-PCR and immunocytochemistry that DA cells express seven different GABA A receptor subunits (␣1, ␣3, ␣4, ␤1, ␤3, ␥1, ␥2 S , and ␥2 L ) and by immunocytochemistry that all subunits are expressed in the intact retina. We show here that at least ␣1, ␤3 and ␥2 subunits are assembled into functional receptors.
I N T R O D U C T I O N
In the vertebrate retina, dopamine is synthesized by a class of neurons that can be either amacrine or interplexiform cells. When the vertebrate retina is stimulated by light, dopamine synthesis and release increase, modulating many of the events that lead to neural adaptation to light. These effects are mediated by metabotropic receptors that are expressed by a large number of cell types throughout the entire retina (see Djamgoz and Wagner 1992; Witkovsky and Dearry 1991) .
In contrast to the wealth of information available on the pharmacological effects of dopamine, little is known about the mechanisms that control its release in the dark and light. Several experiments were carried out measuring the amount of dopamine synthesized or released by the intact retina in different physiological conditions or after addition of various pharmacological agents (see Djamgoz and Wagner 1992) . These studies have shown that the release of dopamine can be manipulated with agonists and antagonists at the GABA A receptors. GABA and its agonist muscimol can in fact block the synthesis and release of dopamine evoked by light (Kirsch and Wagner 1989; Kamp 1980, 1983) . Furthermore, antagonists like bicuculline and picrotoxinin induce dopamine synthesis and release in dark-adapted retinas (Critz and Marc 1992; Ishita et al. 1988 ; Kamp and Morgan 1981; Kirsch and Wagner 1989; Kolbinger and Weiler 1993; Morgan and Kamp 1983; O'Connor et al. 1987; Piccolino et al. 1987) .
These results suggest that GABAergic inhibition plays an important role in the regulation of dopamine release in both light and darkness. However, the identification of the target cell is left unsolved because dopaminergic amacrine cells (DA cells) receive multiple inputs and the pathway responsible for the control of dopamine release consists of multiple neurons.
DA cells are postsynaptic to various types of amacrine cells (Kolb et al. 1990) , and some of them are GABAergic (Kolb et al. 1991; Yazulla and Zucker 1988) suggesting that GABA receptors reside on the DA cells themselves. However, direct evidence can only be obtained by recording from these cells.
Because there are only 450 DA cells in each mouse retina and they cannot be distinguished from neighboring cells on the basis of their morphology, we used transgenic technology to label the surface of DA cells with human placental alkaline phosphatase (PLAP) (Gustincich et al. 1997) . We were then able to identify DA cells in vitro after dissociation of the retina.
We have previously reported that, in absence of synaptic inputs, solitary DA cells fire action potential in a rhythmic fashion. Furthermore, extracellular application of GABA reversibly inhibits the spontaneous discharge through bicuculline-sensitive receptors (Gustincich et al. 1997) , thus proving that DA cells express functional GABA A receptors.
GABA A receptors are pentameric structures that consist of various combinations of at least 16 subunits (Barnard et al. 1998; Bormann 2000; Sieghart 1995) . In situ hybridization and immunocytochemical studies demonstrated that each subunit has a unique distribution in the CNS (Fritschy et al. 1992; Laurie et al. 1992; Wisden et al. 1992) ; furthermore, transfection experiments proved that the various combinations of subunits found in specific regions of the brain have different pharmacological properties (Rabow et al. 1995) . We have recently shown by single-cell RT-PCR experiments that solitary DA cells contain the messages for seven GABA A subunits (␣1, ␣3, ␣4, ␤1, ␤3, ␥1, ␥2 S , and ␥2 L ), and immunocytochemistry with subunit-specific antibodies proved that all subunits are expressed by DA cells in the intact retina, where they are associated to form at least two types of synaptic and multiple extrasynaptic receptors.
In this paper, we characterize the pharmacological properties of GABA A receptors of solitary DA cells, seeking evidence for the functional expression of their repertory of subunit transcripts.
M E T H O D S

Dissociation of the retina and identification of DA cells
Anesthetized, 1-to 3-mo-old mice homozygous for the PLAP transgene (Gustincich et al. 1997) were used. PLAP-expressing cells can be identified in the living state by labeling of their membrane with a monoclonal antibody to PLAP (E6) (De Waele et al. 1982) conjugated to the fluorochrome Cy3 (E6-Cy3) (Gustincich et al. 1997) . Dissociation of the retina by enzymatic digestion and mechanical trituration was performed as previously described (Gustincich et al. 1997) , with a few small changes. After removal of cornea, lens, and vitreous body, the eyecups including the retinas were transferred to 5 ml of digestion buffer (20 U/ml papain, 200 U/ml DNAse I; both from Worthington Biochemical, Freehold, NJ) in Earle's Balanced Salt Solution (EBSS; Sigma, St. Louis, MO). After digestion (45 min, 37°C), the eyecups were transferred to trituration buffer to stop papain activity (5 min, 37°C). This solution contained 1 mg/ml ovomucoid (Worthington), 1 mg/ml bovine serum albumin (Sigma), and 100 U/ml DNAse I (Worthington) in EBSS. Following trituration with fire-polished Pasteur pipettes, the cell suspension was centrifuged at 1,000 rpm (5 min), and the pellet was resuspended in minimum essential medium (MEM; Sigma) containing E6-Cy3 (1:100). The cell suspension was allowed to sediment on a concavalin A (1 mg ml Ϫ1 )-coated coverslip at the bottom of a recording chamber and kept at 37°C in 5% CO 2 -95% O 2 .
Electrophysiology
Recording chambers with solitary retinal cells were mounted on the stage of an inverted microscope (Diaphot 300, Nikon), and E6-Cy3-stained DA cells were identified by scanning the chamber in epifluorescence (535 nm excitation filter; 610 nm barrier filter). Whole cell voltage-clamp and outside-out single-channel recordings were performed with an Axopatch 200A patch-clamp amplifier (Axon Instruments, Foster City, CA) and viewed with an oscilloscope (BK Precision, Chicago, IL) or directly on the screen of a Gateway 4DX2-66 computer. The sample frequency was 20 Hz and 10 kHz in whole cell and single-channel experiments, respectively. Patch pipettes were constructed from borosilicate glass (1.65 mm OD, 1.2 mm ID; A-M Systems, Everett, WA) using a horizontal two-stage electrode puller (BB-CH, Mecanex, Geneva); the electrode resistance ranged from 5 to 7 M⍀. Electrodes were connected to the amplifier via an Ag/AgCl wire. The electrode holder and the headstage were mounted on a piezoelectric, remote-controlled device attached to a three-dimensional micromanipulator (Burleigh Instruments, Fishers, NY). In voltage-clamp experiments, the series resistance of the pipettes was in the range of 12-20 M⍀ and could be compensated up to 95% following cancellation of capacitive transients. Drugs were applied to single cells or excised outside-out patches in the extracellular bath solution by gravity flow through an array of microcapillary tubes. Drugs could be selected using a Teflon Rotary Valve (Rheodyne, Cotati, CA). This application system allowed for a complete solution exchange in the vicinity of the recorded cell within 200 -500 ms.
Recording solutions
The extracellular bath solution for recordings of both whole cell and single-channel currents contained (in mM) 137 NaCl, 5.4 KCl, 1.8 CaCl 2 , 1 MgCl 2 , 5 HEPES, and 10 glucose, pH 7.4. The intracellular solution for recordings of whole cell and single-channel currents contained (in mM) 120 CsCl, 20 TEACl, 1 CaCl 2 , 2 MgCl 2 , 11 EGTA, and 10 HEPES, pH 7.2. Flunitrazepam, zolpidem, alphaxalone, methyl 6,7-dimethoxy-4-ethyl-␤-carboline-3-carboxylate (DMCM) (all RBI, Natick, MA), CL-218872, and loreclezole were prepared as 10-mM stock solutions in DMSO and stored at Ϫ20°C. The maximal final concentration of DMSO was 0.03%. Bicuculline methiodide (RBI) and picrotoxinin (Sigma) were freshly prepared and added to the GABA-containing solution. A 10-mM stock solution of ZnCl 2 (Fluka, Buchs, Switzerland) and pentobarbital (RBI) were prepared in extracellular solution and kept frozen at Ϫ20°C. CL-218872 was a gift from Dr. J. Bormann, and loreclezole was generously provided by Janssen Pharmaceutica (Beerse, Belgium).
Data analysis
Effects of modulatory drugs were expressed as I/I C , the ratio of the GABA-induced peak current in the presence of the drug (I) relative to the control GABA response (I C ), or as percentage drug-induced change of I C . Dose-response curves were fitted with a logistic sigmoidal equation. GABA-activated currents in outside-out patches were analyzed after low-pass filtering at 1 kHz (Ϫ3 dB, 4-pole Bessel filter). The analysis of single-channel amplitudes was carried out with a semi-automatic procedure, where each current step was measured on the computer screen using two cursors. Current-voltage (I-V) relations were obtained by measuring 30 current amplitudes at different membrane potentials (range Ϫ70 to 70 mV). The single-channel conductance of the main state and subconductance levels were derived from the slope of the I-V curves by linear regression. Data are expressed as means Ϯ SE; n is number of DA cells.
R E S U L T S
GABA concentration-response relationships
After enzymatic digestion and mechanical trituration of the retina, DA cells were identified in the living state by labeling of their membrane with E6-Cy3 (Gustincich et al. 1997) . Cells were voltage clamped at Ϫ70 mV with equal concentrations of chloride on either side of the membrane. Under these experimental conditions, we have previously shown that extracellular application of GABA induced a large inward current carried by chloride ions and blocked by bicuculline (Gustincich et al. 1997) .
In this paper we present whole cell patch-clamp recordings carried out from 153 DA cells. A stable gigaseal was established in 82% of the cells. GABA was applied at concentrations ranging from 0.3 to 1,000 M. Desensitization of GABA receptor (GABAR) currents was dose-dependent and became apparent at a GABA concentration of 10 M (Fig. 1A) . The maximal current measured at a saturating concentration of GABA (1,000 M) was variable and ranged in amplitude from Ϫ4.7 to Ϫ8.4 nA with a mean value of Ϫ6.3 Ϯ 0.7 nA (mean Ϯ SE, n ϭ 6).
Dose-response curves for GABA were obtained from six individual DA cells. Their responses to increasing concentrations of GABA were uniform with an increase in relative current amplitude (Fig. 1B) . EC 50 values for individual cells ranged from 5.9 to 10.1 M with a median value of 7.4 M. For each concentration, the data from the cells were pooled and fitted to a sigmoidal logistic function (Fig. 1C) . The mean EC 50 value was 7.4 Ϯ 0.7 M with a Hill coefficient of 1.6 Ϯ 0.3 corresponding to two GABA binding sites on each GABAR. The maximum value of the GABAR current derived by the best fit to the logistic equation was Ϫ6,115 pA compared with a mean peak current value of Ϫ6,283 pA measured in six cells. This indicated that peak current amplitudes were not significantly affected by desensitization or by redistribution of chloride ions even at saturating GABA concentrations.
Inhibition by bicuculline and picrotoxinin
The competitive GABA A receptor antagonist bicuculline (concentration range 0.1-100 M) was co-applied with 10 M GABA. The block of GABAR currents by increasing concentrations of bicuculline is shown in Fig. 2A . Complete doseresponse curves were obtained for six DA cells. The sensitivity of the GABAR current for various concentrations of bicuculline was homogeneous for all neurons examined. Therefore the responses of individual cells were pooled, and the data were fitted to a sigmoidal logistic function (Fig. 2B) . Bicuculline (0.1 M) inhibited GABAR currents by 5%, whereas the current was completely blocked by 100 M ( Fig The open chloride channel blocker picrotoxinin also inhibited the GABA response of DA cells. At a concentration of 10 M, picrotoxinin reduced the peak inward current evoked by GABA to 36% of control values (Table 1 ).
Benzodiazepine binding site shows BZ1 receptor specificity
To study the effects of benzodiazepines on DA cells' GABA A receptors, we co-applied flunitrazepam (1 M) and 3 M GABA. Flunitrazepam potentiated the peak current induced by GABA in all cells tested (Table 1 ). In addition, GABAR currents were uniformly inhibited by the inverse benzodiazepine agonist DMCM (Table 1) .
Next we determined the pharmacology of the benzodiazepine binding site by applying agonists with BZ1-receptor specificity.
FIG. 1. GABA concentration-response relationship of dopaminergic (DA) cells. A:
GABA-induced whole cell currents (holding potential Ϫ70 mV); the concentration of GABA appears above the trace. The bar indicates the duration of the GABA application. B: GABA concentration-response relationships for 6 DA cells plotted individually. The data were normalized to the maximal current obtained with a saturating concentration of GABA (1 mM). The lines represent the best fit of the data to a sigmoidal function. C: absolute current amplitudes of the cells in B were pooled and plotted vs. the GABA concentration. Individual data points denote the mean (ϮSE). The EC 50 and Hill coefficient (n) were derived from the equation of the sigmoidal function that gave the best fit to the data.
When co-applied with 3 M GABA, the imidazopyridine zolpidem (1 M), a BZ1-selective drug, increased more than twofold the peak current evoked by GABA (Fig. 3A) . Doseresponse curves were obtained for seven DA cells; data were pooled and fitted with a sigmoidal logistic function (Fig. 3B) . Zolpidem enhanced GABAR function of DA cells with an EC 50 value of 126 Ϯ 2 nM, a maximal enhancement of 348 Ϯ 9% and a Hill coefficient of 0.9 Ϯ 0.1. CL-218872, another BZ1-selective drug with high affinity for the ␣1 subunit, had a very similar effect on the GABA response of DA cells (Fig. 3C) . When co-applied with 3 M GABA, CL-218872 (1 M) increased more than twofold the peak current induced by GABA (Table 1) , and its effects were completely reversible after wash out (2 min).
These data indicate that benzodiazepine binding sites of DA cell GABA A receptors conform to the traditional definition of the BZ1 type.
In addition, control GABA-induced currents of all DA cells were increased more than twofold by 50 M pentobarbital (Table 1) . At this concentration, application of pentobarbital alone did not induce an inward current. FIG. 2. GABA-induced currents of DA cells are blocked by bicuculline. A: the control response of a DA cell was elicited by 10 M GABA. When co-applied with 10 M GABA, increasing concentrations of bicuculline inhibited the current in a dose-dependent way. The concentrations of bicuculline are given next to each trace. All current traces are from the same cell. The horizontal bar indicates the application period. B: pooled data from 6 DA cells. The current amplitudes were normalized to the control response obtained with 10 M GABA. The data points represent mean (ϮSE). The IC 50 and Hill coefficient (n) were derived from the equation of the sigmoidal function that gave the best fit to the data. Values are expressed as means Ϯ SE; n is the number of cells. I/I c is the ratio of GABA-induced peak current in the presence (I) and absence of the drug (I c ). Drugs were co-applied with 3 M GABA. FIG. 3. GABA receptor (GABAR) of DA cells express type I benzodiazepine-receptor (BZ1) specificity. A: whole cell currents induced by 3 M GABA were reversibly potentiated by zolpidem. B: dose-response curve for zolpidem obtained from 7 DA cells. Current amplitudes were normalized to the response obtained with 3 M GABA and expressed as percent control. Individual data points represent mean (ϮSE). The EC 50 and Hill coefficient (n) were derived from the equation of the sigmoidal function that gave the best fit to the data. C: the BZ1-modulatory drug CL-218872 also augmented GABAinduced whole cell currents. Both CL-218872 and zolpidem were co-applied with 3 M GABA at a concentration of 1 M. The horizontal bars in A and C indicate the application period.
Zn 2ϩ inhibition of GABAR currents
The divalent metal cation Zn 2ϩ has been described as a noncompetitive blocker of GABA A receptor channels (Celentano et al. 1991) . The inhibitory effects of Zn 2ϩ were studied on GABAR currents of DA cells by co-applying Zn 2ϩ (concentration range, 1-1,000 M) and 3 M GABA (Fig. 4A) . Zn 2ϩ inhibition was very similar in all cells tested (n ϭ 7) as reflected by the small standard errors of the data points in the dose-response curve. Currents were hardly affected by 1 M Zn 2ϩ , and all were inhibited by 100 M. Since all DA cells were equally affected with Zn 2ϩ , the individual data were pooled and fitted to a sigmoidal logistic function (Fig. 4B) . The IC 50 of Zn 2ϩ inhibition of GABAR currents was 58.9 Ϯ 8.9 M with a Hill coefficient of 0.8 Ϯ 0.1, and the maximal inhibition of GABAR currents obtained with 1 mM Zn 2ϩ was 94 Ϯ 2%. Even higher concentrations of Zn 2ϩ did not completely block the GABA response leaving a small but substantial current (Fig. 4A) .
The incomplete inhibition of GABAR currents could reflect the presence of more than one subpopulation of GABA A receptors, one Zn 2ϩ -sensitive and the other Zn 2ϩ -insensitive. Likewise, we can assume a single GABAR population displaying incomplete block by Zn 2ϩ . Using recombinant expression systems, it has been shown that the presence of a ␥-subunit leads to lower sensitivity to zinc ions (Fisher and MacDonald 1998; Horenstein and Akabas 1998; Smart 1992; Smart et al. 1991) , and therefore Zn 2ϩ -insensitive GABARs are likely to be modulated by benzodiazepines. We then tested on seven DA cells the possibility that the residual GABAR current after Zn 2ϩ block was mediated by a flunitrazepam-sensitive GABAR subpopulation. First, inward currents elicited by 3 M GABA were potentiated by 1 M flunitrazepam (Fig. 5A) . After wash out of the drug and complete recovery of the control response, GABA-induced currents of the same neuron were inhibited by 100 M Zn 2ϩ to 43 Ϯ 4% of control value (Fig. 5B) . When 1 M flunitrazepam was applied in addition to 100 M Zn 2ϩ , the residual current was 47 Ϯ 6% of the control response augmented by flunitrazepam. While flunitrazepam alone potentiated the GABA response of 214 Ϯ 14%, in the presence of 100 M Zn 2ϩ currents were enhanced by flunitrazepam of 206 Ϯ 10%. Thus Zn 2ϩ -insensitive residual current was no more sensitive to benzodiazepines than the Zn 2ϩ -sensitive GABAR currents. The results of this experiment are summarized in Fig. 5C .
Steroid enhancement of GABAR currents
Varying concentrations of the neuroactive steroid alphaxalone (10 -3,000 nM) were co-applied with 3 M GABA. The lowest concentration tested (10 nM) augmented the GABA response by about 23%, and the GABAR currents were more than doubled with 0.3 M alphaxalone (Fig. 6A) . Dose-response curves were obtained from seven DA cells. Because the cells responded uniformly to increasing concentrations of alphaxalone, individual data were pooled and fitted with a sigmoidal logistic function (Fig. 6B) . The EC 50 value obtained from the best fit to the data points was 360 Ϯ 4 nM with a Hill slope of 1.4 Ϯ 0.2. The maximal potentiation obtained with 3 M alphaxalone was 452 Ϯ 37% which is close to the value obtained from the fit (473 Ϯ 17%).
Effect of loreclezole
Six DA cells were tested for enhancement of GABA (3 M)-induced currents by 1 and 10 M loreclezole, a drug selective for the ␤2 or ␤3 subunits. Loreclezole uniformly potentiated the GABA response in all of these cells in a concentration-dependent way, and the rate of apparent desensitization was enhanced with higher concentrations (Fig. 7A) . Loreclezole (1 M) increased GABAR currents by 43 Ϯ 7%, whereas the GABA response was enhanced by 10 M loreclezole to 207 Ϯ 14%. The effects of different concentrations of loreclezole on GABAR currents are summarized in Fig. 7C .
Single-channel recordings
To determine the single-channel conductance, outside-out patches were pulled from the cell bodies of solitary DA cells pulses were recorded at a holding potential of Ϫ70 mV. Because of the high-density of GABARs on the surface of DA cells, it was not possible to obtain patches that contained only a single GABAR channel. Therefore a detailed kinetic analysis of single-channel properties could not be carried out. Extracellular application of GABA induced bursts of channel openings to multiple conductance levels (Fig. 8A) . The main conductance and a subconductance level were determined by recording GABA-induced single-channel openings at various holding potentials. The data points were fitted with a linear regression line, and the resulting conductances of the current-voltage relationships were 29 and 20 pS, respectively (Fig. 8B) . Because of the small amplitude, the current-voltage relation of the second subconductance state was obtained by connecting the data points at Ϫ70 and 70 mV with a straight line. The slope of this line was 9 pS, representing the conductance of the second sublevel.
The amplitude distribution of the main and two subconductance states were determined in six patches at a holding potential of Ϫ70 mV with 1 M extracellular GABA. The mean current values as determined by Gaussian distributions were Ϫ2.06 Ϯ 0.14 pA for the main level and Ϫ1.55 Ϯ 0.11 pA and Ϫ0.61 Ϯ 0.08 pA, respectively, for the two sublevels (Fig. 8C ).
D I S C U S S I O N
In this study a transgenic mouse line was used in which DA cells were labeled with PLAP, an enzyme that resides on the outer surface of the cell membrane (Gustincich et al. 1997) . After enzymatic digestion and mechanical trituration of the retina, DA cells were identified in the living state by labeling of their membrane with a monoclonal antibody to PLAP conjugated to the fluorochrome Cy3 (E6-Cy3). We have previously shown by single-cell RT-PCR that E6-Cy3-positive neurons are dopaminergic because they contain TH mRNA. Furthermore, we proved that the expression of PLAP on the cell surface did not affect the properties of GABA-gated chloride channels (Gustincich et al. 1997 ). Many studies of GABAR currents after enzymatic digestion of tissue have been reported, showing no alterations of the responses compared with those recorded from cultured neurons (Kapur and MacDonald 1996) .
The pharmacological properties of the GABA A receptors of DA cells were analyzed studying the effects of the application of various drugs that are known to have distinct actions in the presence or absence of specific subunits. Drugs were applied only when stable recordings were obtained, and responses to consecutive applications of 3 M GABA remained constant. We never observed "run-down" of GABA-induced currents during the time course of the recordings (15-20 min). After application and wash out of the drug, GABA was repeatedly applied to ensure complete recovery of the control GABA response.
GABA sensitivity of DA cells
The EC 50 value for acutely isolated DA cells was 7.4 M, which is slightly lower than that in acutely dissociated pyramidal neurons (25.4 M) (Celentano and Wong 1994) , in adult cortical neurons (40.3 M), and in thalamic neurons (23 M) (Oh et al. 1995) . It is one order of magnitude lower than the value measured in unidentified cultured amacrine cells of the rat retina (71 M) (Feigenspan and Bormann 1994) . In cultures of rat hippocampus, rapidly and slowly desensitizing responses to GABA have been observed with EC 50 values of 8.5 and 37.3 M, respectively (Schonrock and Bormann 1993). High-affinity (EC 50 ϭ 6 -8 M) GABA responses have been reported for rat hippocampal neurons, rat nucleus tracti solitarii neurons, and mouse retinal bipolar cells (Nakagawa et al. 1991; Shirasaki et al. 1991; Suzuki et al. 1990 ). The effect of subunit composition on the affinity of GABA A receptors for GABA has been studied by transient expression of ␣1␤3␥2 L , ␣6␤3␥2 L , and ␣6␤3␦ isoforms in mouse fibroblast cells (Saxena and MacDonald 1996) . The isoform containing the ␣6 subunit revealed an increased affinity for GABA (2.2 M) when compared with the ␣1-containing receptor (16.4 M). EC 50 values in the range of 6 -17 M have been reported with recombinant GABA receptors composed of ␣1␤2␥2, ␣5␤2␥2, and ␣5␤1␥2 (Ebert et al. 1994; Sigel et al. 1990 Sigel et al. , 1992 . It has been recently shown that both ␣ and ␤ subunits interact to influence EC 50 values of GABA A receptors (White et al. 1995) .
The individual EC 50 values measured in this study were evenly distributed around the mean, within a range of 5-M GABA concentration. The best fit to both the individual and the mean data points was obtained with a first-order sigmoidal function, suggesting a uniform sensitivity of the GABA A receptors of DA cells. It must be noted, however, that with only six different GABA concentrations tested, small differences in affinities of two or more hypothetical GABA receptor subpopulations could not be resolved.
Benzodiazepine pharmacology of DA cells
Central benzodiazepine receptors have been traditionally classified into two different pharmacological subtypes. BZ1 FIG. 6. GABAR currents are enhanced by the neurosteroid alphaxalone. A: whole cell currents were induced by 3 M GABA (top traces). Superimposed are shown the current traces obtained after co-application of 0.3 and 3 M alphaxalone (bottom traces) to the same cell. Current amplitudes were increased to 208 and 471% of control values, respectively. The bars indicate the duration of the drug application. B: a dose-response relationship for alphaxalone was obtained from the pooled data of 7 DA cells. Current amplitudes were normalized to the response obtained with 3 M GABA and expressed as percent control. Individual data points represent mean (ϮSE). The EC 50 and Hill coefficient (n) were derived from the equation of the sigmoidal function that gave the best fit to the data. sites show high affinity for the triazolopyridazine CL-218872, zolpidem, and some ␤-carbolines, whereas BZ2 sites display low affinity for these ligands and high affinity for flunitrazepam. It is now clear, however, that benzodiazepine-binding sites of GABA A receptors are much more heterogeneous in their affinity for the ligands listed above. For instance a subtype in cerebellar granule cells designated BZ3 is associated with the ␣6 subunit and is insensitive to diazepam (see MacDonald and Olsen 1994) .
We studied the effects of the BZ1-preferring agonists CL-218872 and zolpidem, as well as the benzodiazepine agonist flunitrazepam and the inverse agonist DMCM. The GABA response of all DA cells tested were modulated by these allosteric regulators.
The EC 50 value for zolpidem was 126 nM and thus intermediate between BZ1 and BZ2 receptors. However, maximal enhancement of GABA A receptors currents was 348% compared with 214% by flunitrazepam and 220% by CL-218872.
The benzodiazepine sensitivity of DA cell GABA A receptors can be explained by various combinations of subunits. Expression in oocytes or mammalian cell lines suggested that benzodiazepine sensitivity is conferred by the presence of the ␥2 subunit (Pritchett et al. 1989) . Since all DA cells showed enhancement of the GABA response by flunitrazepam, a likely explanation would be that all DA neurons express the ␥2 subunit. Furthermore, all GABA A receptor currents were positively modulated by CL-218872 and zolpidem, compounds indicative of a BZ1 benzodiazepine binding site; these findings are therefore consistent with the presence of the ␣1 subunit.
Recombinant GABA A receptors containing the ␣4 subunit (Wisden et al. 1991) in combination with one ␤ and the ␥2 subunits are insensitive to benzodiazepines such as diazepam. Because DA cells, however, express multiple types of GABA A receptors, the observed benzodiazepine sensitivity does not rule out the presence of a functional receptor containing ␣4.
Zn 2ϩ sensitivity of the GABA A receptors
GABA receptor currents from all DA cells displayed low sensitivity to Zn 2ϩ . Currents were maximally inhibited to 6% of control values with an IC 50 of 59 M. The effects of Zn 2ϩ on GABA responses depend on the isoforms of GABA A receptors that are expressed (Celentano et al. 1991; Draguhn et al. 1990; Smart and Constanti 1990; Smart et al. 1991; Xie and Smart 1991) . Recombinant GABA receptor isoforms expressed in human embryonic kidney cells composed of ␣1 or ␤1 subunits subunit to these GABA receptor subtypes, Zn 2ϩ (100 M) had no inhibitory effect on GABA-induced currents. In addition, Zn 2ϩ sensitivity was also modified by the ␣ subunit, with GABA A receptors that contained ␣6 being more sensitive to Zn 2ϩ than those that contained ␣1 (Saxena and MacDonald 1996) . Finally, expression of the ␥ subunit together with ␣6 and ␤3 confers a 10-fold higher sensitivity to Zn 2ϩ when compared with the ␣6␤3␥2 GABA receptor isoform (Saxena and MacDonald 1996) . Therefore it has been proposed that when the ␣1 or ␥2 subunit is present in recombinant GABA receptor isoforms, the sensitivity to Zn 2ϩ inhibition is lost (Draguhn et al. 1990; Smart et al. 1991) .
As shown by Saxena and MacDonald (1996) , the presence of the ␥ subunit causes a decrease in the susceptibility to Zn 2ϩ inhibition rather than a total loss. Thus the moderate to low effect of Zn 2ϩ on DA cell GABA responses is compatible with the presence of ␥2 in all receptors expressed. However, the incomplete inhibition of GABA-induced currents by saturating concentrations of Zn 2ϩ may result from the presence of at least two subpopulations of GABA receptors, one containing ␥2 (Zn 2ϩ insensitive), the other lacking ␥2 (Zn 2ϩ sensitive). Based on the studies of recombinant GABA A receptors, the Zn 2ϩ -insensitive isoform containing ␥2 should display high affinity for benzodiazepines like flunitrazepam. The Zn 2ϩ -insensitive residual current, however, was no more benzodiazepine sensitive than were the total GABA-induced currents, resulting from the hypothetical activation of more than one GABA A receptor population. These data suggested a single population of moderately Zn 2ϩ -sensitive GABA receptors rather than two or more subpopulations.
Modulation by neurosteroids and loreclezole
Although there is no absolute subunit specificity for steroid modulation of GABA A receptor function, it has been shown that subunit composition affects their action Korpi and Luddens 1993; Lan et al. 1991; Puia et al. 1990 Puia et al. , 1993 Shingai et al. 1991) . The greater potentiation of neurosteroids in the spinal cord has been attributed to regionspecific expression of ␣3 (Lambert et al. 1995; Lan et al. 1991) , whereas the ␦ subunit inhibits neurosteroid modulation of recombinant GABA A receptors (Zhu et al. 1996) . Recombinant receptors containing ␣1 are more sensitive to the modulatory activity of neurosteroids than those containing ␣6, whereas the type of ␤ subunit does not appear to play a significant role (Zhu et al. 1996) .
We have observed a large potentiation of GABA-induced chloride currents (452%) when the neuromodulator alphaxalone was applied together with GABA. The variability of the effect at higher steroid concentrations might be due to a combination of allosteric modulation and direct opening of GABAgated chloride channels. The strong enhancement of DA cell GABA responses by alphaxalone is in agreement with the expression of a GABA A receptor that lacks the ␦ subunit.
A new allosteric modulatory site on the GABA A receptor ␤ subunit has been described . The action of the broad-spectrum anticonvulsant loreclezole depends on the type of ␤ subunit present in the receptor complex: receptors containing ␤2 or ␤3 have more than 300-fold higher affinity for loreclezole than receptors containing ␤1. A single amino acid residue present in both ␤2 and ␤3, but not ␤1 has been shown to confer sensitivity to the modulatory action of loreclezole ). In addition, loreclezole potentiation does not require the presence of either an ␣ or a ␤ subunit .
We have observed a dose-dependent potentiation of GABA responses by loreclezole, indicating the presence of GABA A receptors containing the ␤2 and/or ␤3 subunits. However, the presence of ␤1 cannot be ruled out from these experiments, since a loreclezole-insensitive receptor population would remain undetected. The modulatory effects of loreclezole on GABA responses of DA cells were less pronounced than previously reported for recombinant receptors. Because receptors that contained ␤1 did not contribute to the overall potentiation of GABA-evoked currents, these results could indicate that DA cells did not express a unique population of GABA receptors.
Which GABA A receptor subunits are expressed by DA cells?
We have previously shown with single-cell RT-PCR experiments, that DA cells contained the messages for seven GABA A subunits: ␣1, ␣3, ␣4, ␤1, ␤3, ␥1, ␥2 S , and ␥2 L (Gustincich et al. 1999) . By immunocytochemistry with subunit-specific antibodies, we have confirmed that all subunits were translated and expressed by DA cells in the intact retina.
Such a complexity in GABA A receptor composition is not new. Three other types of neurons, hippocampal pyramidal cells (Nusser et al. 1996) and granule cells of both cerebellum and dentate gyrus (Laurie et al. 1992; Nusser et al. 1995 Nusser et al. , 1998 , exhibit a similar richness in subunits.
With the exception of ␣4, six of the subunits formed clusters on the surface of DA cells that were interpreted as postsynaptic active zones containing GABA A receptors. The postsynaptic clusters distributed throughout the dendritic tree contained the ␣3 subunit associated with ␤3 and, less frequently, ␤1, whereas clusters containing the ␣1 subunit were confined to large dendrites. We were surprised that ␥ subunits were not colocalized with the ␣3 subunit, but the antibodies to ␥1 and ␥2 stained fewer synapses.
We therefore speculated that a receptor consisting of ␣1, ␤1, and ␥2 subunits was localized at postsynaptic active zones on large dendrites, whereas a second type of receptor containing ␣3 and ␤3 subunits was postsynaptic at contacts distributed throughout the dendritic tree. Both types of synapses would be present on the vitreal aspect of the perikaryon.
It is unclear which postsynaptic structures are present in solitary DA cells after enzymatic digestion and mechanical trituration of the retina. We do not know whether the recorded GABA-evoked currents derive exclusively from extrasynaptic receptors of the cell body or from postsynaptic receptors localized on the most vitreal aspect of the perikaryon and/or along the larger dendrites. Therefore the effects of drug application could reflect the participation of different receptor populations.
The physiological data show that ␣1, ␤3, and ␥2 subunits are incorporated into functional receptors at the surface of solitary DA cells. In fact, the BZ1 pharmacology indicates that these cells express GABA A receptors containing ␣1 and ␥2 subunits. The combination ␣1␤2␥2 is the most abundant in the brain (McKernan and Whiting 1996) and is considered as the equivalent to the BZ1 subtype, but the nature of the ␤ subunit does not appear to be essential for determining benzodiazepine pharmacology (Benke et al. 1994; Hadingham et al. 1993) . We can then speculate that we are recording currents mediated by ␣1␤1␥2 or ␣1␤3␥2 receptors. These could be localized extrasynaptically and, for ␣1␤1␥2, on large dendrites. Furthermore, in the rat cerebral cortex, 19% of the GABA A receptors have both ␤1 and ␤3 subunits (Li and De Blas 1997) , raising the possibility of a receptor consisting of ␣1␤1␤3␥2.
Small populations of native receptors containing both ␣1 and ␣3 have been detected in the CNS, and evidence for the combination ␣1␣3␤␥2 has been obtained (Duggan et al. 1991; McKernan et al. 1991; Mertens et al. 1993 ). However, we failed to detect co-immunolocalization of ␣1 and ␣3, but we cannnot exclude the presence of this combination in the cell body. Because ␣3 has been colocalized with ␤3 on DA cells, we can speculate that these two subunits form a ␣3␤3␥2 receptor. ␣3␤␥2/␥3 constitutes approximately 17% of the total GABA A receptor repertory (McKernan and Whiting 1996) . This combination confers BZ2 benzodiazepine pharmacology, but unfortunately no specific agonists or antagonists at this subtype are available. Interestingly, ␣3␤␥2 is found in cholinergic and monoaminergic neurons, and thus could be involved in the control of the release of norepinephrine and dopamine in other regions of the brain (Fritschy et al. 1992; Gao et al. 1993) . Alternatively, ␣3 and ␤3 could form a functional receptor by themselves.
GABA A receptors containing the ␣4 subunit were shown to be insensitive to benzodiazepines and to be colocalized with the ␦ subunit (Laurie et al. 1992; Wisden et al. 1992 ), although ␣4 is also present in regions of the brain where ␦ is not expressed. Therefore ␣4 could be expressed extrasynaptically in a distinct GABA receptor population of DA cells.
Small populations of receptors containing more than one type of ␥ subunit have been identified ), but most receptors appear to contain only one type (Mossier et al. 1994; Quirk et al. 1994) . Immunoprecipitation studies have shown that ␥2 and ␥3 can exist in the same receptor complex, but ␥1 does not co-precipitate with another ␥ subunit ). Since we have detected both ␥1 and ␥2 subunits, this could indicate the presence of at least two receptor populations with different ␥ subunits.
In conclusion, we have provided evidence that in DA cells at least the ␣1, ␤3, and ␥2 subunits are assembled into functional GABA A receptors. In absence of pharmacological tools specific for the other subunits, we could not obtain definitive evidence that also ␣3, ␣4, ␤1, and ␥1 are part of functional receptors, although this is a very likely possibility. Thus the meaning of the subunit diversity of the GABA A receptors of DA cells remains to be clarified. On the basis of the physiology alone, we could not predict the complexity of the GABA A receptor subunit composition revealed in DA cells by RT-PCR applied to individual cells. On the other hand, it is well known that the results of immunocytochemistry are complicated by the vagaries of the interaction between antibody epitopes and the chemical fixatives required for microscopy. Our results therefore emphasize the crucial importance of combining all available technical approaches to the study of a complex receptor in a minuscule cell population.
